Kinase domain mutations reported in imatinib-resistant patients. The most frequent mutations fall into 3 categories that emphasize their structural role in imatinib binding: nucleotide binding p-loop mutations, direct contact points of imatinib, and activation loop mutations. For space considerations, single-letter amino acid codes are used here in place of 3-letter codes.